Effect of Ovarian Stimulation with Recombinant FSH for In Vitro Fertilization (IVF) on Anti MÃ¼llerian Hormone (AMH) Levels as an Early Marker of Ovarian Reserve by Hapsari, Kartika
Research Report
Effect of Ovarian Stimulation with Recombinant FSH for In Vitro
Fertilization (IVF) on Anti Müllerian Hormone (AMH) Levels
as an Early Marker of Ovarian Reserve
Pengaruh Stimulasi Ovarium FSH rekombinan dengan Fertilisasi In Vitro (IVF) pada tingkat
Hormon Anti Müllerian (HAM) sebagai Penanda Dini Cadangan Ovarium
Kartika Hapsari1, Budi Wiweko1, Joedo Prihartono2
1Department of Obstetrics and Gynecology
2Department of Community Medicine
Medical Faculty of Indonesia University/
Dr. Cipto Mangunkusumo Hospital
Jakarta
INTRODUCTION
Fertility problems in Indonesia is increasing. Accord-
ing to a report from the Department of Health, Indo-
nesia, in 2010, approximately 12% of couples of
child-bearing age have fertility issues. Causes of in-
fertility are classified into three groups; 40% of the
causes are attributed to women, 40% attributed to
men, and 30% idiopathic (unexplained, unknown
causes).1 Management of infertility depends on the
main cause. Problems arise when a variety of methods
to achieve pregnancy had been done to no avail.
There are currently various methods of assisted re-
productive technology (ART), both available and un-
der development, which can solve the problem of in-
fertility for couples of child-bearing age who had pre-
Abstract
Objective: To analyze the effect of ovarian stimulation with re-
combinant FSH on AMH levels as a marker of ovarian reserve in
patients undergoing IVF.
Method: This study is an intervention study which compares
AMH levels pre- and post-ovarian stimulation with recombinant
FSH in IVF participants to determine the effect of ovarian stimula-
tion on ovarian reserve. This study was conducted at Dr. Cipto Ma-
ngunkusumo Hospital, Jakarta, from January to July 2010. AMH
levels measured are AMH levels pre- and post-stimulation taken on
the day of hCG evaluation.
Result: Of 56 patients undergoing IVF treatment, 20 subjects
were eligible for study. The mean age of the patients was 35. 3 ± 4.0
years, the mean duration of infertility 9.1 ± 5.7 years, the mean BMI
21.9 ± 3.4 kg/m2, the median AMH level pre-stimulation was 4.0
ng/ml and the total dosage of FSH used was 2747.5 ± 1076.3 IU/
day, the mean duration of ovarian stimulation was 9 ± 3 days. Of the
20 subjects recruited, 11 patients (55%) had a decrease in AMH le-
vels, and the remaining 9 patients (45%) did not. Data analysis
showed that the decrease in AMH levels was not statistically signi-
ficant (p = 0.295) [AMH1; median 4.0 ng/ml (range 2.2 - 5.9) and
AMH2; median 3.2 ng/ml (range 1.6 - 4.8)].
Conclusion: AMH levels decrease following ovarian stimulation
with recombinant FSH is not statistically significant, so it can be
concluded that ovarian stimulation in IVF has no effect on ovarian
reserve.
[Indones J Obstet Gynecol 2011; 35-2: 70-3]
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Abstrak
Tujuan: Menganalisis pengaruh perangsangan ovarium dengan
FSH-rekombinan terhadap kadar AMH sebagai tolak ukur cadang-
an ovarium pada pasien peserta FIV.
Metode: Penelitian ini merupakan penelitian intervensi yang ber-
tujuan untuk membandingkan AMH pra- dan pasca-perangsangan
ovarium dengan FSH rekombinan pada peserta FIV untuk menilai
pengaruh perangsangan ovarium terhadap perubahan cadangan
ovarium. Penelitian dilakukan di Rumah Sakit Dr. Cipto Mangun-
kusumo, Jakarta. Penelitian berlangsung bulan Januari hingga Juli
2010. Kadar AMH yang dinilai adalah kadar AMH pra- perang-
sangan ovarium dan pasca-perangsangan yang diambil pada hari
pemeriksaan hCG.
Hasil: Dari 56 pasien baru peserta program FIV, didapatkan 20
subjek yang memenuhi kriteria inklusi. Rerata umur pasien adalah
35,3 ± 4,0 tahun, lama infertilitas pasien 9,1 ± 5,7 tahun, IMT 21,9
± 3,4 kg/m2, nilai tengah kadar AMH awal 4,0 ng/ml dan total dosis
FSH yang dipakai adalah 2747,5 ± 1076,3 IU/hari, rerata periode
perangsangan ovarium dilakukan selama 9 ± 3 hari. Dari 20 subjek
penelitian didapatkan 11 pasien (55%) mengalami penurunan AMH
dan sisanya 9 pasien (45%) yang tidak mengalami penurunan. Dari
analisis didapatkan penurunan kadar AMH yang tidak bermakna
(p = 0,295) dengan nilai median AMH1 4,0 ng/ml (rentang 2,2 - 5,9)
dan median AMH2 3,2 ng/ml (rentang 1,6 - 4,8).
Kesimpulan: Kadar AMH menurun secara tidak bermakna se-
telah proses perangsangan ovarium dengan FSH rekombinan, se-
hingga dapat dikatakan bahwa proses perangsangan ovarium pada
FIV tidak berpengaruh langsung pada cadangan ovarium.
[Maj Obstet Ginekol Indones 2011; 35-2: 70-3]
Kata kunci: cadangan ovarium, AMH, FSH rekombinan, pe-
rangsangan ovarium, IVF
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viously tried various ways to achieve pregnancy with
no satisfactory results. Of assisted reproduction tech-
niques, IVF is the most commonly used.2 In this me-
thod, recombinant FSH injection was given to stimu-
late follicle development, a process known as control-
led ovarian stimulation.2 This process is a crucial part
of the IVF treatment, as ovarian stimulation will pro-
duce more oocytes, therefore, increasing the number
of embryo available for tranfer.2 Various hormonal
medications and methods used to stimulate the ovaries
have been developed over time. One of the earliest
method used was the combination of clomiphene cit-
rate and human menopausal gonadotropin (hMG) de-
rived from the urine of postmenopausal women. Fol-
lowed by synthetic gonadotropin-releasing hormone
(GnRH) analogs and recombinant FSH.
In the last 2 years, there were a significant number
of women who underwent ovarian stimulation through
IVF programs as well as through artificial insemina-
tions, moreover, in the world, there is a definite up-
ward trend of this number. In developed countries,
approximately 56.1 - 80% of infertile couples seek
treatment for infertility, and 17 - 30% will undergo
IVF program.3
The increase in this number is accompanied with
concern about the occurrence of premature meno-
pause as a side effect of ovarian stimulation. This the-
ory is based on the possibility of accelerated antral
follicle uptake due to the recombinant FSH given.
Pines and colleagues, in 2002, reported that 55 - 60%
of women who underwent ovarian stimulation will ex-
perience menopause 5 years earlier than those who
did not.4
This finding was further refuted by studies which
reported that ovarian reserve does not undergo sig-
nificant decrease post-controlled ovarian stimulation.
Among these studies were Chan et al., 2005, who per-
formed ovarian reserve test (ORT) post stimulation
by measuring FSH levels5; and Frattarelli et al., 2000,
who measured the number of antral follicles.6 These
studies stated that ovarian reserve does not undergo
significant decrease after stimulation. This can be
confirmed by evaluating levels of biomarkers of ova-
rian reserve pre- and post-ovarian stimulation. Esta-
blished biomarkers of ovarian reserve used were fol-
licle stimulating hormone (FSH), basal estradiol (E2)
and basal antral follicle (FAB). The most novel me-
thod currently used is by determining Anti Müllerian
Hormone (AMH) levels. AMH has been reported to
be a strong predictor of ovarian reserve with a sensi-
tivity and specificity of 90.9% compared to FSH, E2,
and FAB combined.7 This can be accounted to its
characteristics; AMH levels does not change signifi-
cantly throughout the menstrual cycle, has a direct
correlation with age, produced by pre-antral and antral
follicles, directly inhibit primordial follicle depletion
and FSH-stimulated growth on follicles. Owing to
these characteristics, it can be said that AMH reflects
the number of follicles more accurately, it also func-
tions to regulate folliculogenesis and oocyte matura-
tion.7,8 Previous study done by Wiweko and collea-
gues stated that changes in serum AMH levels occur
earlier than FAB and serum FSH changes, making it
a better predictor to immediately evaluate ovarian re-
serve.9
METHODS
This study is an intervention study which aims par-
ticipants to determine the effect of ovarian stimulation
on ovarian reserve by comparing AMH levels pre-
and post-ovarian stimulation with recombinant FSH
in IVF. Study population is all patients who partici-
pated in IVF program and underwent ovarian stimu-
lation process at Dr. Cipto Mangunkusumo Hospital,
Jakarta, between January 2010 and July 2010.
Following inclusion criteria were used; women un-
derwent IVF program, normal ovaries, regular 28 -
30 days menstrual cycle, gave consent to participate
in the study, did not smoke. Exclusion criteria used
were; history of ovarian procedure, ovarian stimula-
tion, radiotherapy and or chemotherapy.
On the second day of the menstrual cycle, 5 cc of
venous blood was taken from each patient and stored
at -80°C. After 30 minutes, blood samples were cen-
trifuged at 3500 rpm for 15 minutes. Subsequently,
the levels of serum E2, FSH dan AMH were measured
at Makmal Terpadu Imunoendokrinologi (MTIE) Fa-
kultas Kedokteran Universitas Indonesia. Determina-
tion of serum E2 (pg/ml) was done with AxSYM Es-
tradiol Microparticle Enzyme Immunoassay (MEIA,
Abbott). Determination of serum FSH (m IU/ml) was
done with AxSYM Estradiol Microparticle Enzyme
Immunoassay (MEIA, Abbott). Determination of se-
rum AMH (ng/ml) was done with enzyme-immuno-
metric (ELISA, DSL, Abbott).
On the second day of the menstrual cycle, trans-
vaginal USG was done to each patient using ALOKA
SSD 3500 ultrasound machine. Each examination was
performed by an obstetrics and gynecology specialist
at Yasmin Clinic to count the number of follicles with
diameter of 2 - 5 mm, with minimum 10 follicles as
a sign of good ovarian reserve. The examinations
were done in blinded fashion (without looking at
medical records).
After all examinations had been done, IVF program
was commenced, beginning with ovarian stimulation
by recombinant FSH injection. Ovarian response was
evaluated by counting the number of antral follicles
with transvaginal USG done using ALOKA SSD 3500
ultrasound machine by an obstetrics and gynecology
specialist at Yasmin Clinic during ovarian stimulation
with recombinant FSH; serum E2 levels were also
measured. Ovarian response is defined as good if the
transvaginal USG examination showed minimum
three antral follicles with a diameter of ≥ 18 mm; and
serum E2 > 600 pq/ml. When good ovarian response
had been achieved, hCG was administered. After 36
hours, ovum pick up was done. The final step was
embryo transfer.
Two weeks after embryo transfer, 10 cc of venous
blood was drawn for each patient at Yasmin Clinic
and Makmal, Dr. Cipto Mangunkusumo Hospital. The
first 5 cc was used to measure quantitave ß hCG level
and ensure pregnancy, while the remaining 5 cc was
used to measure AMH level post-ovarian stimulation.
AMH levels measured were then compared to the le-
vels pre-ovarian stimulation. Datas collected were do-
cumented on papers and analyzed with SPSS 12. After
editing and coding, study data was burned on a mag-
netic disc for electronic data recording. Then, data
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was processed and prepared in distribution table to
analyze mean, median, and distribution, in accordance
with study aim.
RESULTS
Between January and July 2010, there were 56 new
couples participating in IVF program at Yasmin Cli-
nic, Department of Obstetrics and Gynecology, Dr.
Cipto Mangunkusumo Hospital. Of the 56 patiens, 20
subjects were eligible for study.
Table 1. Distribution of study subjects by characteristics.
Characteristics Subjects (n = 20)
Type of infertility (%)
Primary 16 (80)
Secondary  4 (20)
Problem (%)
Endometriosis  3 (15)
DOR  4 (20)
PCOS  3 (15)
Persistent Follicle  2 (10)
Bilateral Occlusion  2 (10)
Sperm abnormalities  6 (35)
Age (years) 35,3 ± 4,0
Duration of infertility (years)  9,1 ± 5,7
BMI (kg/m2) 21,9 ± 3,4
FSH (mIU/ml)  7,5 ± 4,0
E2 (pg/ml)  63,2 ± 61,3
FAB (follicle)  10,9 ± 8,9 
Total FSH (IU)  2747,5 ± 1076,3
AMH pre- (ng/dl)  4,0 ± 4,1
Abbreviations: DOR = Diminished Ovarium Reserve; PCOs = Polycys-
tic Ovary Syndrome.
To assess the effect of ovarian stimulation on AMH
levels, a study was done to compare AMH levels prior
to ovarian stimulation (AMH1) and 3 weeks after ova-
rian stimulation on IVF (AMH2). Data collected was
tested with Shapiro-Wilk normality test, it was found
that data distribution was not normal. Wilcoxon test
was used to compare the median AMH1 and AMH2
levels. From the analysis, it was found that decrease in
AMH level was not significant (p = 0.295) with follow-
ing values; AMH1; median 4.0 ng/ml, range 2.2 - 5.9
and AMH2; median 3.2 ng/ml, range 1.6 - 4.8.
DISCUSSION
According to Lee et al., 2010, the decrease happens
because; first - FSH depress AMH expression, second
- increase in estradiol during controlled ovarian stimu-
lation will inhibit AMH secretion, and third - the re-
duction in the number of small antral follicle (there
is a strong notion that AMH levels correlate with the
number of small antral follicle).10,11 AMH levels will
rise again to levels before ovarian stimulation, pro-
bably due to decrease in exogenous FSH levels and
subsequent loss of inhibition on AMH secretion. It
can be said that this decrease is only temporary.
Changes in AMH level could be observed, there
was a significant decrease in AMH level on the day
of hCG administration after ovarian stimulation with
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Figure 1. Comparison of AMH levels pre- (AMH1) and 3 weeks
post-stimulation (AMH2). The line on the bars shows median,
and (°) shows statistically insignificant decrease in ovarian re-
serve (p > 0.05).
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Figure 2. Fluctuation in AMH levels during controlled ovarian
stimulation in IVF. Changes were significant (p < 0.001).10
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recombinant FSH, but this will eventually rise to base
level after 2 weeks post embryo transfer or 1 month
after ovarian stimulation. This AMH level dynamics
described in the study by Lee et al, 2010, is consistent
with the finding from this study which shows that
AMH levels does not decrease significantly, this is
because the AMH levels evaluated were AMH levels
at base (pre-stimulation) and at 2 weeks after embryo
transfer.11
Of the 20 subjects recruited, AMH decrease was
found in 11 patients (55%), no decrease was found
in the remaining 9 patients (45%). Variables from
these two groups were compared in Table 2.
Table 2. Variables and its correlation with AMH level changes.
Variable
Decrease (n = 11) No decrease (n = 9)
p
Mean SD Mean SD
Age 33.3 3.2 37.8 3.5 0.007
Duration of
infertility* 7.0 4.1 11.7 6.6 0.080
BMI 22.6 3.7 21.1 3.0 0.342
FSH* 6.0 2.3 9.1 4.9 0.156
E2* 61.7 67.9 165.1 56.6 0.965
FAB* 11,3 7,2 5,2 4,8 0,851
Total FSH* 2809.1 953.3 2672.2 1266.3 0.710
AMH pre* 6.5 4.1 1.0 1.1 0.000
*Mann Whitney formula
The mean age of all patients was 35.3 years, the
mean age of patients with AMH level decrease was
33.3 years with mean AMH1 level of 6.5, and the
mean age of patients with no decrease in AMH level
was 37.8 years with mean AMH1 level of 1.0. There
were significant differences in both mean age and
AMH1 level of the two groups (p = 0.007 and p =
0.000). This leads to the notion that age and AMH
levels pre-stimulation influence AMH levels post-
ovarian stimulation.
In the group with younger age (< 36 years), there
was a marked decrease of AMH levels post-ovarian
stimulation. This may be owing to the higher AMH
levels pre-stimulation. More decrease in AMH levels
due to FSH-related inhibition was seen. Whereas, in
the older aged group (> 36 years), AMH levels pre-
stimulation were already low, so that the FSH-related
inhibition effect was relatively less prominent.
Studies by de Vat and colleagues, Van Rooj and
colleagues, and Wiweko and colleagues reported that
age does have a strong correlation with AMH level.10-
12 The older a women is, the more AMH level will
decrease, and this decrease happens before other pa-
rameters of ovarian reserve (FSH, E2, Inhibin B and
number of antral follicles) change.
CONCLUSION
AMH levels decrease following ovarian stimulation
with recombinant FSH in IVF is not statistically sig-
nificant and the process of ovarian stimulation in IVF
has no effect on AMH levels as the decrease in AMH
levels was found to be insignificant, however it is still
unclear whether this stimulation does not affect ova-
rian reserve.
RECOMMENDATIONS
A follow up study - in a larger scale with serial AMH
level monitoring done at more appropriate times du-
ring ovarian stimulation in IVF and post stimulation,
is needed in order to evaluate ovarian reserve more
accurately.
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